IMS Health announced Thursday it reached a $5.2-billion deal to be acquired by TPG Capital and the CPP Investment Board. Under the agreement, IMS shareholders will receive $22.00 for each share, representing a premium of approximately 50 percent over the closing price on October 16.
Closing of the transaction is expected to occur by the end of the first quarter of 2010, the company said.
